ARKG (ARK Genomic Revolution) Stock Analysis - Politician Trades

ARK Genomic Revolution (ARKG) is a publicly traded Financial Services sector company. As of May 21, 2026, ARKG trades at $29.39 with a market cap of $0 and a P/E ratio of 0.00. ARKG moved +5.25% today. Year to date, ARKG is -1.47%; over the trailing twelve months it is +35.07%. Its 52-week range spans $17.51 to $34.39. Rallies surfaces ARKG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded ARKG stock?

Rallies tracks politician and congressional stock disclosures for ARKG, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

ARKG Key Metrics

Key financial metrics for ARKG
MetricValue
Price$29.39
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.38%
52-Week High$34.39
52-Week Low$17.51
Volume17.47K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ARKG News

ARKG Analyst Consensus

ARKG analyst coverage data. Average price target: $0.00.

Common questions about ARKG

Which politicians traded ARKG stock?
Rallies tracks politician and congressional stock disclosures for ARKG, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ARKG?
Yes. Rallies tracks politician and congressional stock disclosures for ARKG, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ARKG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARKG. It does not provide personalized investment advice.
ARKG

ARK Genomic Revolution